Pricing & Positioning Comparison
Where competitors actually price, sit and win.
A defensible cross-competitor pricing and positioning comparison framework — across geographies, indications and channels — for launch and competitive teams.
"How should we price and position against a fully-mapped competitor set?"
Useful pricing comparison goes beyond list price to net price, gross-to-net, payer placement, contracting strategy and country-by-country positioning.
Pricing comparison done badly is a list-price grid. Done well, it is a country-by-country, net-price, multi-layer positioning model that drives launch and brand decisions.
What we’re seeing in the data.
List price hides net economics
Net price after rebates, GPO contracts and payer deals is the only meaningful comparison.
Country pricing diverges sharply
EU reference pricing networks force coordination; APAC requires localized strategy.
Positioning is multi-layer
Clinical positioning, payer positioning and patient positioning often point in different directions.
Indications-based pricing emerging
Same molecule, different prices by indication — increasingly accepted in EU.
How to think about it.
-
01
Map list and net by competitor
Use IQVIA, claims and contracting intelligence.
-
02
Decompose by geography
Country-specific list, net, payer placement.
-
03
Score positioning layers
Clinical, payer, patient narratives.
-
04
Forecast price erosion
LoE, biosimilar entry, indication expansion.
-
05
Run scenario pricing
Multiple launch-price scenarios with peak NPV.
What separates a good answer from a defensible one.
Net pricing is opaque — model ranges.
NICE / G-BA decisions cascade through reference pricing.
Bundled deals shift net economics non-obviously.
Per-indication pricing changes forecast.
Where the signal comes from.
Common questions.
Why isn’t list price enough?
Net is often 30–60% below list. Strategy off list price is structurally wrong.
How do you handle confidential rebates?
Triangulate from public filings, payer interviews and gross-to-net disclosures with explicit ranges.
Want this answered on your data?
We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.
Talk to a strategist